$JNJ
Johnson & Johnson
XNYS•Health Care•Pharmaceutical Preparations
Johnson & Johnson
XNYS•Health Care•Pharmaceutical Preparations
Why is JNJ up today? It is at $270.47 (+1.25%), and our scanner flagged it 97 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JNJ spikes, and full due diligence on JNJ — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $JNJ 97 times in the last 30 days. Create a free account to track $JNJ, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how JNJ traded in the last session, Friday (last price and move above). Our scanner fired 11 unusual-volume and momentum alerts on JNJ on Friday, peaking at 17.1x its normal volume. A recent catalyst in the news: “Late-breaking Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA® (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness.” Early read: bullish.
Likely catalystJOHNSON & JOHNSON: Q3 FY2026 results, three months to Sep 27, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 13, 2026 · 7 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Forminard Elizabeth Officer | Sold (automatic/other) | -13K | sold 43% | 17K | $3.7M at $284.39 | Nov 12, 26 |
Forminard Elizabeth Officer | Other | 13K | added 77% | 30K | $2.0M at $151.41 | Nov 12, 26 |
Schmid Timothy Officer | Sold (automatic/other) | -34K | sold 57% | 25K | $9.2M at $274.74 | Sep 2, 26 |
Schmid Timothy Officer | Other | 34K | added 100% | 48K | $4.4M at $131.94 | Sep 2, 26 |
Taubert Jennifer L Officer | Sold (automatic/other) | -15K | sold 7.2% | 194K | $4.0M at $263.36 | Aug 17, 26 |
Taubert Jennifer L Officer | Other | 15K | added 7.7% | 209K | $1.7M at $115.67 | Aug 17, 26 |
Duato Joaquin Officer | Sold (automatic/other) | -123K | sold 31% | 276K | $32.2M at $261.00 | Aug 13, 26 |
Duato Joaquin Officer | Other | 123K | added 45% | 399K | $14.3M at $115.67 | Aug 13, 26 |
Forminard Elizabeth Officer | Sold (automatic/other) | -16K | sold 48% | 17K | $4.1M at $255.93 | Aug 6, 26 |
Forminard Elizabeth Officer | Other | 9K | added 40% | 33K | $1.2M at $131.94 | Aug 6, 26 |
Duato Joaquin Officer | Sold (automatic/other) | -48K | sold 15% | 276K | $12.5M at $258.06 | Aug 5, 26 |
Broadhurst Vanessa Officer | Sold (automatic/other) | -23K | sold 50% | 23K | $5.8M at $251.27 | Jul 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.






The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Curated groups JNJ belongs to. Tap one to see every member with today's move and why the group is moving.
The market is closed. Here is how JNJ traded in the last session, Friday (last price and move above). Our scanner fired 11 unusual-volume and momentum alerts on JNJ on Friday, peaking at 17.1x its normal volume. A recent catalyst in the news: “Late-breaking Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA® (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness.” Early read: bullish.
JNJ last traded at $270.47, up 1.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Yes. JNJ currently has a dividend yield of about 1.98% ($5.36 per share per year), with the next ex-dividend date on Nov 24. Dividend figures can change; this is not investment advice.
The JNJ Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JNJ 97 times in the last 30 days.
JNJ (Johnson & Johnson) trades on XNYS, with a market cap of about $651.81B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JNJ for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$JNJ discussion
Sign in to ask a question or join the discussion.